Ensign Peak Advisors Inc Increases Stake in Intuitive Surgical, Inc. $ISRG

Ensign Peak Advisors Inc grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% during the 2nd quarter, HoldingsChannel reports. The firm owned 472,760 shares of the medical equipment provider’s stock after buying an additional 433 shares during the quarter. Ensign Peak Advisors Inc’s holdings in Intuitive Surgical were worth $256,903,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in ISRG. Aaron Wealth Advisors LLC grew its position in Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after buying an additional 19 shares during the period. J. W. Coons Advisors LLC lifted its stake in shares of Intuitive Surgical by 1.4% in the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after buying an additional 20 shares in the last quarter. Exencial Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 3.1% in the first quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock worth $327,000 after buying an additional 20 shares in the last quarter. Evergreen Capital Management LLC grew its stake in Intuitive Surgical by 0.5% during the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after acquiring an additional 20 shares in the last quarter. Finally, Rise Advisors LLC lifted its stake in Intuitive Surgical by 5.6% in the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after purchasing an additional 20 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 3.3%

Shares of NASDAQ:ISRG opened at $564.64 on Thursday. The firm has a 50 day simple moving average of $487.92 and a 200-day simple moving average of $503.76. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market capitalization of $202.41 billion, a PE ratio of 74.69, a P/E/G ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period last year, the business earned $1.84 EPS. Intuitive Surgical’s revenue for the quarter was up 22.9% compared to the same quarter last year. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have issued reports on ISRG. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the company a “buy” rating in a report on Wednesday, October 22nd. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Evercore ISI lifted their price objective on Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Rothschild & Co Redburn boosted their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Insiders Place Their Bets

In related news, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the sale, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. This represents a 81.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 116,164 shares of company stock worth $61,916,172. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.